Correlation of symptom clusters of schizophrenia with absolute powers of main frequency bands in quantitative EEG

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages

  Gross, Andres ^a,d   Joutsiniemi, Sirkka Liisa ^b,d   Rimon, Ranan ^c   Appelberg, Björn ^a,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d Tammiharju Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DIAZEPAM; HYPNOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DELTA RHYTHM; ELECTROENCEPHALOGRAPHY; HUMAN; MENTAL DISEASE; POSITIVE AND NEGATIVE SYNDROME SCALE; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUANTITATIVE ANALYSIS; RELAPSE; SCALP; SCHIZOPHRENIA; SYMPTOMATOLOGY; THETA RHYTHM;

EID: 33749064333     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-23     Document Type: Article

References (24)

1. Hughes JR, John ER: Conventional and quantitative electroencephalography in psychiatry. J Neuropsychiatry Clin Neurosci 1999, 11:190-208.
2. Nuwer M: Assessment of digital EEG, quantitative EEG, and EEG brain mapping, report of the American Academy of Neurology and the American Clinical, Neurophysiology Society. Neurology 1997, 49:277-292.
3. John ER, Prichep LS, Alper KR, Mas FG, Cancro R, Easton P, Sverdlov L: Quantitative electrophysiological characteristics and subtyping of schizophrenia. Biol Psychiatry 1994, 36:801-826.
4. Gattaz WF, Mayer S, Ziegler P, Platz M, Gasser T: Hypofrontality on topographic EEG in schizophrenia Correlations with neuropsychological and psychopathological parameters. Eur Arch Psychiatry Clin Neurosci 1992, 241:328-332.
5. Guenther W, Davous P, Godet J-L, Guillibert E, Breitling D, Rondot P: Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping. Biol Psychiatry 1988, 23:295-311.
6. Williamson PC, Kutcher SP, Cooper PW, Snow WG, Szalai JP, Kaye H, Morrison SL, Willinsky RA, Mamelak M: Psychological, topographical EEG and CT scan correlates of frontal lobe function in schizophrenia. Psychiatry Res 1989, 29:137-149.
7. Fehr T, Kissler J, Moratti S, Wienbruch C, Rockstroh B, Elbert T: Source distribution of neuromagnetic slow waves and MEG-delta activity in schizophrenic patients. Biol Psychiatry 2001, 50:108-116.
8. Harris AWF, Williams L, Gordon E, Bahramali H, Slewa-Younan S: Different psychopathological models and quantified EEG in schizophrenia. Psychol Med 1999, 9:1175-1181.
9. Harris AWF, Bahramali H, Slewa-Younan S, Gordon E, Williams L, Li WM: The topography of quantified electroencephalography in three syndromes of schizophrenia. Int J Neurosci 2001, 107:265-278.
10. Liddle PF: Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987, 17:49-57.
11. Kay S, Fiszbein A, Opler L: The Positive and Negative Syndrome Rating Scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-76.
12. Gross A, Joutsiniemi SL, Rimon R, Appelberg B: Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry 2004, 37:119-122.
13. Karson CN, Coppola R, Morihisa JM, Weinberger DR: Computed Electroencephalographic activity in schizophrenia. Arch Gen Psychiatry 1987, 4:514-517.
14. Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H: Neuroanatomy of "hearing voices": a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cerebr Cortex 2004, 1:91-96.
15. Davis PA: Evaluation of the EEG of schizophrenic patients. Am J Psychiatry 1939, 96:107.
16. Kornetsky C, Mirsky AF: On certain psychopharmacological and physiological differences between schizophrenic and normal persons. Psychopharmacology 1965, 8:309-318.
17. Dierks T: Equivalent EEG sources determined by FFT approximation in healthy subjects, schizophrenic and depressive patients. Brain Topography 1992, 4:207-213.
18. Czobor P, Volavka J: Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients. J Clin Psychopharmacology 1993, 13:332-342.
19. Saletu B, Küfferle B, Anderer P, Grünberger J, Steinberger K: EEG brain-mapping in schizophrenics with predominantly positive and negative symptoms. Eur Neuropsychopharm 1990, 1:27-36.
20. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE: Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990, 147:1457-1462.
21. Kawasaki Y, Maeda Y, Sakai N, Higashima M, Yamaguchi N, Koshino Y, Hisada K, Suzuki M, Matsuda H: Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures. Psychiatry Res 1996, 67:49-58.
22. Itil TM, Saletu B, Davis S: EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. Biol Psychiatry 1972, 5:1-13.
23. Joutsiniemi SL, Gross A, Appelberg B: Marked clozapine-induced slowing of EEG background over frontal, central, and parietal scalp areas in schizophrenic patients. J Clin Neurophysiol 2001, 18:9-13.
24. Yamadera H, Kato M, Ueno T, Tsukahara Y, Okuma T: Pharmaco-EEG mapping of diazepam effects using different references and absolute and relative power. Pharmacopsychiatry 1993, 26:254-258.